This little-known biotech could have a big hit on its hands with VK2735, a GLP-1 weight loss drug candidate.

Discover the Latest in Research Peptides at Biotech Labz Supply Sebastopol, United States - January 3, 2026 / Biotech ...

Excellergy has been snapped up by the Swiss pharma only five months after emerging with $70 million in funds. The Palo Alto, ...

Techcyte has been named 2025 Infectious Disease Testing Solution of the Year by the BioTech Breakthrough Awards, a leading ...

Some investors and analysts believe the pharma’s $6.7 billion offer is justified given Terns’ recent stock run. Others are ...

The drugmaker has been seeking to bolster its pipeline as its top-selling drug, Keytruda, is set to lose patent protection.

After several years of IPO drought in the biotech industry, the public market is picking up again. Will the trend keep going ...

March 27 (Reuters) - Swiss drugmaker Novartis said on Friday it will buy California-based biotech company Excellergy in a ...

Attend or sponsor our commercial real estate event in San Francisco: Bay Area Life Sciences & Biotech Conference.

Why Enveda, Faeth Therapeutics, Gilgamesh Pharma, and Argo Biopharma are among the most innovative companies in biotech right ...

An Allston mixed-use project has secured its first lab tenant since opening last year. King Street Properties' Allston ...